| Metric | FY2026 | FY2025 | FY2024 | FY2023 |
|---|---|---|---|---|
| Net sales | $565.2M-9.8% | $626.6M-3.1% | $646.7M-1.0% | $653.3M |
| Cost of goods sold (excluding depreciation and amortization) | $263.6M-17.1% | $318.1M-1.1% | $321.7M+3.8% | $309.9M |
| Gross profit | $301.6M-2.2% | $308.5M-5.1% | $325.0M-5.4% | $343.4M |
| Selling, general and administrative expenses | $310.5M-8.0% | $337.6M+0.9% | $334.5M-0.8% | $337.2M |
| Restructuring expense | $1.2M-84.2% | $7.7M | — | — |
| Operating loss | -$10.2M+72.4% | -$36.9M-285.2% | -$9.6M-253.6% | $6.2M |
| Interest expense | $5.2M+14.2% | $4.6M+9.6% | $4.2M+13.8% | $3.7M |
| Other (loss) income, net | $295K+70.5% | $173K-81.3% | $923K+145.5% | $376K |
| Loss before income taxes | -$15.1M+63.5% | -$41.2M-222.2% | -$12.8M | — |
| Income tax expense | $1.2M-50.0% | $2.4M+182.8% | -$2.9M-504.2% | $708K |
| Net loss | -$16.2M+62.7% | -$43.6M-338.8% | -$9.9M-542.6% | $2.2M |
| Less: Net income attributable to noncontrolling interest | $139K+135.6% | $59K+447.1% | -$17K+70.7% | -$58K |
| Net loss attributable to controlling interest | -$16.4M+62.5% | -$43.7M-340.1% | -$9.9M-530.7% | $2.3M |
| Weighted average shares of common stock outstanding | 34.6M+3.7% | 33.4M+1.3% | 33.0M+0.6% | 32.8M |
| Net loss per share attributable to controlling interest | -$470.00+64.1% | -$1310.00-336.7% | -$300.00-528.6% | $70.00 |
| Weighted average shares and equivalents outstanding | 34.6M+3.7% | 33.4M+1.3% | 33.0M-0.1% | 33.0M |
Source: SEC EDGAR XBRL. % change vs prior period shown where available.
Source: SEC EDGAR 10-K and 10-Q filings. Up to 10 years annual / 16 quarters shown.